These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 33670754)

  • 1. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
    Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains.
    Soto-Rojas LO; Campa-Córdoba BB; Harrington CR; Salas-Casas A; Hernandes-Alejandro M; Villanueva-Fierro I; Bravo-Muñoz M; Garcés-Ramírez L; De La Cruz-López F; Ontiveros-Torres MÁ; Gevorkian G; Pacheco-Herrero M; Luna-Muñoz J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
    Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
    Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pericyte: a forgotten cell type with important implications for Alzheimer's disease?
    Winkler EA; Sagare AP; Zlokovic BV
    Brain Pathol; 2014 Jul; 24(4):371-86. PubMed ID: 24946075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
    Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
    Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán RM; Javadov S; Fossati S
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
    Solis E; Hascup KN; Hascup ER
    J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
    Deane R; Zlokovic BV
    Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
    Canepa E; Fossati S
    Front Neurol; 2020; 11():573324. PubMed ID: 33488493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Voluntary Physical Exercise on the Neurovascular Unit in a Mouse Model of Alzheimer's Disease.
    Andrade-Guerrero J; Orta-Salazar E; Salinas-Lara C; Sánchez-Garibay C; Rodríguez-Hernández LD; Vargas-Rodríguez I; Barron-Leon N; Ledesma-Alonso C; Diaz-Cintra S; Soto-Rojas LO
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Tau on Neurotoxicity and Cerebral Vasculature Impairment Associated with Alzheimer's Disease.
    Rather MA; Khan A; Jahan S; Siddiqui AJ; Wang L
    Neuroscience; 2024 Aug; 552():1-13. PubMed ID: 38871021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
    Sagare AP; Bell RD; Zlokovic BV
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants for Treatment of Alzheimer's Disease.
    Grossmann K
    J Alzheimers Dis; 2020; 77(4):1373-1382. PubMed ID: 32925057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological changes induced by amyloid-β in Alzheimer's disease].
    Takata K; Kitamura Y; Taniguchi T
    Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.